At 13-11 overall, Harmony grabbed a fourth-place finish in District 31-4A play with a 4-6 record to qualify for the ...
Civil society organisations have urged Odisha government to reschedule and change route of Goddess Kali immersion procession in Cuttack on Friday (October 24, as it coincides with Friday Namaaz at ...
Some residents in Harmony Borough, Beaver County remain under a boil water advisory Tuesday days following a water main break. In an alert posted on the borough's website, an advisory remains in place ...
Assistant Attorney General Sam Gonyea argues before the state Supreme Court against Adam Montgomery's appeal of his murder conviction. Adam Montgomery was sentenced last year to more than 50 years in ...
The county Board of Supervisors Wednesday unanimously approved a proposed housing development in the communities of Harmony Grove and Elfin Forest, despite opposition from some residents concerned ...
Pristine nature, free wildlife, ancient glaciers, pristine waters. Katon Karagay is a hidden jewel of untouched wilderness in Central Asia. Katon Karagay is Kazakhstan’s easternmost region. Amid the ...
Reactions from the Muslim community and other groups over the past few days have shown that social cohesion is worth protecting, says Faishal Ibrahim. His remarks came after a man was charged for his ...
Sept 24 (Reuters) - Harmony Biosciences (HRMY.O), opens new tab said on Wednesday its experimental drug for a rare genetic disorder failed to meet the main goal in a late-stage trial, sending its ...
Harmony Biosciences’ $60 million bet on a once-failed Fragile X candidate has gone off the rails. Two years after picking up ZYN002 despite a midphase flop, the biotech has reported that a ...
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) released topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ZYN002 in Fragile X syndrome (FXS). Fragile X syndrome ...
The Reconnect study of ZYN002 in FXS did not achieve its primary endpoint due to an unexpected high placebo response rate. ZYN002 is a synthetic cannabidiol gel, devoid of THC, designed for ...
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
PLYMOUTH MEETING, Pa., September 24, 2025--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback